A new investigational drug
for Glaucoma or High Eye Pressure


Learn about a clinical research study
of an investigational drug for adults
with Glaucoma or High Eye Pressure.


What is The Apollo Study

The Apollo Study is a clinical research study evaluating an investigational
drug for glaucoma
or high eye pressure. If you have been diagnosed
with Glaucoma or High Eye Pressure, we hope you will consider
participating in The Apollo Study.

Who can participate in The Apollo Study?


  • - Age 18 or older
  • - Diagnosed with glaucoma or high eye pressure
  • - Willing to complete study requirements

More About Glaucoma and High Eye Pressure

Glaucoma is a complex eye disease in which nerve damage leads to vision loss and blindness if left untreated. High eye pressure alone does not cause Glaucoma, however high eye pressure has been found to be a significant risk factor for the disease. An estimated 2.2 million Americans are currently living with Glaucoma, and many more are living with High Eye Pressure. Source: http://www.glaucoma.org/glaucoma/

How can I find out if I qualify?

To be contacted by a research team member in your area, please contact us here by submitting your informaiton at the form below.

Where is The Apollo Study being conducted?

The Apollo Study is being conducted at local research sites throughout the US.

What are the potential risks and benefits associated with participating in this study?

Potential Benefits Include:
  • - Access to an investigational drug that isn't available
  • - Access to study-related care from leading doctors and researchers
  • - Contribute to research that may improve the lives of others
  • - No cost investigational drug
  • Potential Risks Include:
  • - Not being able to choose if you will receive investigational drug or placebo
  • - The investigational drug may not work for you
  • - Side effects may occur

What happens during the Apollo Study?

Before beginning The Apollo Study, you will be screened for eligibility. If you are determined to be eligible, and you agree to participate, you will be randomly placed into one of the dosing groups, with certain groups receiving placebo (an inactive substance).

You and your doctor will not know your dosing group assignment, however in the event of an emergency; this information will be provided to your doctor.

After you join the study, you will begin a 12 to 13 month involvement in the study, which will include 8 or 9 visits to the study clinic. During your visit, you will receive the study drug, as well as have doctors monitor your health and progress through various related tests and assessments.

FAQ on Clinical Trials

Please refer below to frequently asked questions about clinical research trials.

What is a clinical trial?
A clinical trial (also called clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people and ways to improve health. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
What happens during a clinical trial?
The clinical trial team includes doctors and nurses as well as social workers and other health care professionals. They check the health of the participant at the beginning of the trial, give specific instructions for participating in the trial, monitor the participant carefully during the trial, and stay in touch after the trial is completed. Some clinical trials involve more tests and doctor visits than the participant would normally have for an illness or condition. For all types of trials, the participant works with a research team. Clinical trial participation is most successful when the protocol is carefully followed and there is frequent contact with the research staff.
What happens during a clinical trial?
Informed consent is the process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. If the participant's native language is not English, translation assistance can be provided. Then the research team provides an informed consent document that includes details about the study, such as its purpose, duration, required procedures, and key contacts. Risks and potential benefits are explained in the informed consent document. The participant then decides whether or not to sign the document. Informed consent is not a contract, and the participant may withdraw from the trial at any time.
How is the safety of the participant protected?
The ethical and legal codes that govern medical practice also apply to clinical trials. In addition, most clinical research is federally regulated with built in safeguards to protect the participants. The clinical trial will be performed in accordance with the guidelines set by the World Medical Assembly (Declaration of Helsinki, last amendment in Seoul, October 2008). Prior written approval of the study protocol and of the informed consent form will be obtained from the appropriate local Medical Ethics Review Board. The trial follows a carefully controlled protocol, a study plan which details what researchers will do in the study. As a clinical trial progresses, researchers report the results of the trial at scientific meetings, to medical journals, and to various government agencies. Individual participants' names will remain secret and will not be mentioned in these reports.
Does a participant continue to work with a primary health care provider while in a trial?
Yes. Most clinical trials provide short-term treatments related to a designated illness or condition, but do not provide extended or complete primary health care. In addition, by having the health care provider work with the research team, the participant can ensure that other medications or treatments will not conflict with the protocol.
Can a participant leave a clinical trial after it has begun?
Yes. A participant can leave a clinical trial, at any time. When withdrawing from the trial, the participant should let the research team know about it, and the reasons for leaving the study.

Contact

To be contacted by a research team member in your area, please fill out the following information. You may also call 1-855-7STUDY7.

SUBMIT

Thank you for your message. We will try to answer as soon as possible